| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Virology, Hebrew University-Hadassah Medical School
and2 Department of Medicine A, Liver Unit, Hadassah University Hospital, Jerusalem, Israel
Human papillomavirus (HPV) type 16 is highly associated with cervical cancer, but it seems that cofactors such as hormones affect its potential oncogenicity. We have analysed the HPV-16 gene expression in response to sex hormones and glucocorticoids in SiHa cells, a human cervical carcinoma cell line. An eightfold induction of HPV-16 transcripts was obtained in oestrogen-treated SiHa cells. Of the five HPV-16 transcripts detected in these cells only the two major ones, the 4.6 kb and the 4.1 kb mRNA species, were affected by oestrogen. Since the five transcripts span the E6 and E7 open reading frames of the HPV-16 genome, these results suggest that the expression of the various transcripts is differentially controlled, as oestrogen regulates only two of them. We have identified in the HPV-16 genome seven different regions with a high degree of similarity to the oestrogen-responsive element consensus sequence (GGTCANNNTGACC). These sequences are located throughout the entire HPV-16 genome. Progesterone or dexamethasone had no detectable stimulatory effect on the various transcripts of HPV-16 in SiHa cells, up to 24 h after treatment of the cells. Since the E6 and E7 open reading frames have been associated with the oncogenic potential of HPV-16, the effect of oestrogen on the transcription of these viral genes may be of biological relevance in the malignant transformation of HPV-16-infected cervical cells.
Keywords: papillomavirus, human, cervical carcinoma cell line, oestrogen treatment
Received 17 November 1988;
accepted 10 April 1989.
This article has been cited by other articles:
|
|
 |
|
  S. Vaccarella, R. Herrero, M. Dai, P. J.F. Snijders, C. J.L.M. Meijer, J. O. Thomas, P. T. Hoang Anh, C. Ferreccio, E. Matos, H. Posso, et al. Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2148 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baldwin, K.-W. Huh, and K. Munger Human papillomavirus e7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J. Virol., July 1, 2006; 80(13): 6669 - 6677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Nair, R. Luthra, N. Kirma, Y.-G. Liu, L. Flowers, D. Evans, and R. R. Tekmal Induction of Aromatase Expression in Cervical Carcinomas: Effects of Endogenous Estrogen on Cervical Cancer Cell Proliferation Cancer Res., December 1, 2005; 65(23): 11164 - 11173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Richardson, M. Abrahamowicz, P.-P. Tellier, G. Kelsall, R. du Berger, A. Ferenczy, F. Coutlee, and E. L. Franco Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1149 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Brake and P. F. Lambert Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model PNAS, February 15, 2005; 102(7): 2490 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Meng, Y. Zhao, A. Nag, M. Zeng, G. Dimri, Q. Gao, D. E. Wazer, R. Kumar, H. Band, and V. Band Human ADA3 Binds to Estrogen Receptor (ER) and Functions As a Coactivator for ER-mediated Transactivation J. Biol. Chem., December 24, 2004; 279(52): 54230 - 54240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wang, X. Li, L. Wang, Y.-H. Feng, R. Zeng, and G. Gorodeski Antiapoptotic Effects of Estrogen in Normal and Cancer Human Cervical Epithelial Cells Endocrinology, December 1, 2004; 145(12): 5568 - 5579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Castellsague and N. Munoz Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Bromberg-White and C. Meyers The Upstream Regulatory Region of Human Papillomavirus Type 31 Is Insensitive to Glucocorticoid Induction J. Virol., August 28, 2002; 76(19): 9702 - 9715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M L Shew, R McGlennen, N Zaidi, M Westerheim, M Ireland, and S Anderson Oestrogen receptor transcripts associated with cervical human papillomavirus infection Sex. Transm. Inf., June 1, 2002; 78(3): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Webster, A. Taylor, and K. Gaston Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins J. Gen. Virol., January 1, 2001; 82(1): 201 - 213. [Abstract] [Full Text]
|
|
|
|
|
|
L. Jin, M. Qi, D.-Z. Chen, A. Anderson, G.-Y. Yang, J. M. Arbeit, and K. J. Auborn Indole-3-Carbinol Prevents Cervical Cancer in Human Papilloma Virus Type 16 (HPV16) Transgenic Mice Cancer Res., August 1, 1999; 59(16): 3991 - 3997. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
